1. Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway


    Luo Jiang et al, 2020, OncoTargets and Therapy CrossRef
  2. A 4-gene-based hypoxia signature is associated with tumor immune microenvironment and predicts the prognosis of pancreatic cancer patients
    Jianfeng Ding et al, 2021, World Journal of Surgical Oncology CrossRef
  3. Integrated Network Pharmacology and Molecular Docking to Reveal the Mechanism of Tetrandrine in Tumor Chemoresistance
    Xuehua Luo et al, 2021, Oncologie CrossRef
  4. QSAR Research of Novel Tetrandrine Derivatives against Human Hepatocellular Carcinoma
    Meng Wang et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  5. Network Pharmacology Approach Reveals the Potential Immune Function Activation and Tumor Cell Apoptosis Promotion of Xia Qi Decoction in Lung Cancer
    Song Zhang et al, 2019, Medical Sciences CrossRef
  6. Tetrandrine Ameliorates Myocardial Ischemia Reperfusion Injury through miR-202-5p/TRPV2
    Wei Zhao et al, 2021, BioMed Research International CrossRef
  7. New perspectives on the potential of tetrandrine in the treatment of non-small cell lung cancer: bioinformatics, Mendelian randomization study and experimental investigation
    Jihang Luo et al, 2024, Aging CrossRef
  8. Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways
    Chuansheng Yang et al, 2022, Molecules CrossRef
  9. Progress on structural modification of Tetrandrine with wide range of pharmacological activities
    Liuying Mo et al, 2022, Frontiers in Pharmacology CrossRef
  10. Anticancer Activity of Tetrandrine by Inducing Apoptosis in Human Breast Cancer Cell Line MDA-MB-231 In Vivo
    Chun-hui Wang et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  11. Targeting the two-pore channel 2 in cancer progression and metastasis
    Kathryn A. Skelding et al, 2022, Exploration of Targeted Anti-tumor Therapy CrossRef
  12. Plant Alkaloid Tetrandrine Is a Nuclear Receptor 4A1 Antagonist and Inhibits Panc-1 Cell Growth In Vitro and In Vivo
    Hyo-Seon Lee et al, 2022, International Journal of Molecular Sciences CrossRef